|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Di Meo A, Bartlett J, Cheng Y, Pasic MD
and Yousef GM: Liquid biopsy: A step forward towards precision
medicine in urologic malignancies. Mol Cancer. 16:802017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh R, Ansari JA, Maurya N, Mandhani A,
Agrawal V and Garg M: Epithelial-to-mesenchymal transition and its
correlation with clinicopathologic features in patients with
urothelial carcinoma of the bladder. Clin Genitourin Cancer.
15:e187–e197. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cao W, Zhao Y, Wang L and Huang X:
Circ0001429 regulates progression of bladder cancer through binding
miR-205-5p and promoting VEGFA expression. Cancer Biomark.
25:101–113. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li B, Xie F, Zheng FX, Jiang GS, Zeng FQ
and Xiao XY: Overexpression of CircRNA BCRC4 regulates cell
apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer. J
Huazhong Univ Sci Technolog Med Sci. 37:886–890. 2017.PubMed/NCBI
|
|
7
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qiu L, Tang Q, Li G and Chen K: Long
non-coding RNAs as biomarkers and therapeutic targets: Recent
insights into hepatocellular carcinoma. Life Sci. 191:273–282.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang Y, Cheung BB, Atmadibrata B, Marshall
GM, Dinger ME, Liu PY and Liu T: The regulatory role of long
noncoding RNAs in cancer. Cancer Lett. 391:12–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vishnubalaji R, Shaath H, Elkord E and
Alajez NM: Long non-coding RNA (lncRNA) transcriptional landscape
in breast cancer identifies LINC01614 as non-favorable prognostic
biomarker regulated by TGFβ and focal adhesion kinase (FAK)
signaling. Cell Death Discov. 5:1092019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang H, Chen T, Xu S, Zhang S and Zhang M:
Long noncoding RNA FOXC2-AS1 predicts poor survival in breast
cancer patients and promotes cell proliferation. Oncol Res.
27:219–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen C, He W, Huang J, Wang B, Li H, Cai
Q, Su F, Bi J, Liu H, Zhang B, et al: LNMAT1 promotes lymphatic
metastasis of bladder cancer via CCL2 dependent macrophage
recruitment. Nat Commun. 9:38262018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang
Y, Jia L, Li S, Xie W and Yang D; Cancer Genome Atlas Research
Network, : lncRNA epigenetic landscape analysis identifies EPIC1 as
an oncogenic lncRNA that interacts with MYC and promotes cell-cycle
progression in cancer. Cancer Cell. 33:706–720. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu M, Chen X, Lin K, Zeng K, Liu X, Pan B,
Xu X, Xu T, Hu X, Sun L, et al: The long noncoding RNA SNHG1
regulates colorectal cancer cell growth through interactions with
EZH2 and miR-154-5p. Mol Cancer. 17:1412018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Su J, Zhang E, Han L, Yin D, Liu Z, He X,
Zhang Y, Lin F, Lin Q, Mao P, et al: Long noncoding RNA BLACAT1
indicates a poor prognosis of colorectal cancer and affects cell
proliferation by epigenetically silencing of p15. Cell Death Dis.
8:e26652017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin L, He Y, Tang S and Huang S: LncRNA
GHET1 predicts poor prognosis in hepatocellular carcinoma and
promotes cell proliferation by silencing KLF2. J Cell Physiol.
233:4726–4734. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu
Q, Tong X, Yang W, Xu Q, Huang D and Tu K: A novel lncRNA
MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by
targeting miR-194-5p/FOXA1 axis. Mol Cancer. 18:282019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan Y, Wang YF, Su HF, Fang N, Zou C, Li
WF and Fei ZH: Decreased expression of the long noncoding RNA
LINC00261 indicate poor prognosis in gastric cancer and suppress
gastric cancer metastasis by affecting the epithelial-mesenchymal
transition. J Hematol Oncol. 9:572016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Xiao X, Chang R and Zhang C:
Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a
migration inhibitor in esophageal squamous cell carcinoma. J Cell
Biochem. 121:468–481. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen W, Hang Y, Xu W, Wu J, Chen L, Chen
J, Mao Y, Song J, Song J and Wang H: BLACAT1 predicts poor
prognosis and serves as oncogenic lncRNA in small-cell lung cancer.
J Cell Biochem. 120:2540–2546. 2019. View Article : Google Scholar
|
|
21
|
Fang C, He W, Xu T, Dai J, Xu L and Sun F:
Upregulation of lncRNA DGCR5 correlates with better prognosis and
inhibits bladder cancer progression via transcriptionally
facilitating P21 expression. J Cell Physiol. 234:6254–6262. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shan H, Yang Y, Zhu X, Han X, Zhang P and
Zhang X: FAM83H-AS1 is associated with clinical progression and
modulates cell proliferation, migration, and invasion in bladder
cancer. J Cell Biochem. 120:4687–4693. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rui X, Wang L, Pan H, Gu T, Shao S and
Leng J: LncRNA GAS6-AS2 promotes bladder cancer proliferation and
metastasis via GAS6-AS2/miR-298/CDK9 axis. J Cell Mol Med.
23:865–876. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu Z, Huang B, Zhang Q, He X, Wei H and
Zhang D: NOTCH1 regulates the proliferation and migration of
bladder cancer cells by cooperating with long non-coding RNA HCG18
and microRNA-34c-5p. J Cell Biochem. 120:6596–6604. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cao X, Xu J and Yue D: LncRNA-SNHG16
predicts poor prognosis and promotes tumor proliferation through
epigenetically silencing p21 in bladder cancer. Cancer Gene Ther.
25:10–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhai X and Xu W: Long noncoding RNA ATB
promotes proliferation, migration, and invasion in bladder cancer
by suppressing MicroRNA-126. Oncol Res. 26:1063–1072. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tuo Z, Zhang J and Xue W: LncRNA TP73-AS1
predicts the prognosis of bladder cancer patients and functions as
a suppressor for bladder cancer by EMT pathway. Biochem Biophys Res
Commun. 499:875–881. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Paraskevopoulou MD, Vlachos IS, Karagkouni
D, Georgakilas G, Kanellos I, Vergoulis T, Zaggana K, Tsanakas P,
Floros E, Dalamagas T and Hatzigeorgiou AG: DIANA-LncBase v2:
Indexing microRNA targets on non-coding transcripts. Nucleic Acids
Res. 44:D231–D238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chou CH, Shrestha S, Yang CD, Chang NW,
Lin YL, Liao KW, Huang WC, Sun TH, Tu SJ, Lee WH, et al: MiRtarBase
update 2018: A resource for experimentally validated
microRNA-target interactions. Nucleic Acids Res. 46:D296–D302.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
33
|
Zhuang L, Yang Z and Meng Z: Upregulation
of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in tumor tissues predicted
worse overall survival and disease-free survival in hepatocellular
carcinoma patients. Biomed Res Int. 2018:78973462018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yao H, Lu F and Shao Y: The E2F family as
potential biomarkers and therapeutic targets in colon cancer. Peer
J. 8:e85622020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu TP, Wang WY, Ma P, Shuai Y, Zhao K,
Wang YF, Li W, Xia R, Chen WM, Zhang EB and Shu YQ: Upregulation of
the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by
epigenetically silencing EphB3 through EZH2 and LSD1, and predicts
poor prognosis in gastric cancer. Oncogene. 37:5020–5036. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xing F, Liu Y, Wu SY, Wu K, Sharma S, Mo
YY, Feng J, Sanders S, Jin G, Singh R, et al: Loss of XIST in
breast cancer activates MSN-c-Met and reprograms microglia via
exosomal miRNA to promote brain metastasis. Cancer Res.
78:4316–4330. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li C, Wan L, Liu Z, Xu G, Wang S, Su Z,
Zhang Y, Zhang C, Liu X, Lei Z and Zhang HT: Long non-coding RNA
XIST promotes TGF-β-induced epithelial-mesenchymal transition by
regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Cancer Lett. 418:185–195. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao YW, Ma F, Xie YC, Ding MG, Luo LH,
Jiang S, Rao L and Liu XL: Sp1-induced upregulation of the long
noncoding RNA TINCR inhibits cell migration and invasion by
regulating miR-107/miR-1286 in lung adenocarcinoma. Am J Transl
Res. 11:4761–4775. 2019.PubMed/NCBI
|
|
39
|
Chen Z, Liu H, Yang H, Gao Y, Zhang G and
Hu J: The long noncoding RNA, TINCR, functions as a competing
endogenous RNA to regulate PDK1 expression by sponging miR-375 in
gastric cancer. Onco Targets Ther. 10:3353–3362. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Terashima M, Tange S, Ishimura A and
Suzuki T: MEG3 long noncoding RNA contributes to the epigenetic
regulation of epithelial-mesenchymal transition in lung cancer cell
lines. J Biol Chem. 292:82–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang Y, Wu J, Jing H, Huang G, Sun Z and
Xu S: Long noncoding RNA MEG3 inhibits breast cancer growth via
upregulating endoplasmic reticulum stress and activating NF-κB and
p53. J Cell Biochem. 120:6789–6797. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gong F, Dong D, Zhang T and Xu W: Long
non-coding RNA FENDRR attenuates the stemness of non-small cell
lung cancer cells via decreasing multidrug resistance gene 1 (MDR1)
expression through competitively binding with RNA binding protein
hur. Eur J Pharmacol. 853:345–352. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu TP, Huang MD, Xia R, Liu XX, Sun M, Yin
L, Chen WM, Han L, Zhang EB, Kong R, et al: Decreased expression of
the long non-coding RNA FENDRR is associated with poor prognosis in
gastric cancer and FENDRR regulates gastric cancer cell metastasis
by affecting fibronectin1 expression. J Hematol Oncol. 7:632014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cao B, Liu C and Yang G: Down-regulation
of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via
activation of PI3K/Akt pathway. Biomed Pharmacother. 107:185–193.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Deva Magendhra Rao AK, Patel K, Korivi
Jyothiraj S, Meenakumari B, Sundersingh S, Sridevi V, Rajkumar T,
Pandey A, Chatterjee A, Gowda H and Mani S: Identification of
lncRNAs associated with early-stage breast cancer and their
prognostic implications. Mol Oncol. 13:1342–1355. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen JL, Lin ZX, Qin YS, She YQ, Chen Y,
Chen C, Qiu GD, Zheng JT, Chen ZL and Zhang SY: Overexpression of
long noncoding RNA LINC01419 in esophageal squamous cell carcinoma
and its relation to the sensitivity to 5-fluorouracil by mediating
GSTP1 methylation. Ther Adv Med Oncol. 11:17588359198389582019.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen Y, Bi F, An Y and Yang Q:
Identification of pathological grade and prognosis-associated
lncRNA for ovarian cancer. J Cell Biochem. 120:14444–14454. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kondo A, Nonaka A, Shimamura T, Yamamoto
S, Yoshida T, Kodama T, Aburatani H and Osawa T: Long noncoding RNA
JHDM1D-AS1 promotes tumor growth by regulating angiogenesis in
response to nutrient starvation. Mol Cell Biol. 37:e00125–e00117.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li Y, Wang H and Huang H: Long non-coding
RNA MIR205HG function as a ceRNA to accelerate tumor growth and
progression via sponging miR-122-5p in cervical cancer. Biochem
Biophys Res Commun. 514:78–85. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li P, Xing W, Xu J, Yuan D, Liang G, Liu B
and Ma H: MicroRNA-301b-3p downregulation underlies a novel
inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell
lung cancer. Stem Cell Res Ther. 10:1442019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhu D, Yu Y, Wang W, Wu K, Liu D, Yang Y,
Zhang C, Qi Y and Zhao S: Long noncoding RNA PART1 promotes
progression of non-small cell lung cancer cells via JAK-STAT
signaling pathway. Cancer Med. 8:6064–6081. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yin Z, Ma T, Yan J, Shi N, Zhang C, Lu X,
Hou B and Jian Z: LncRNA MAGI2-AS3 inhibits hepatocellular
carcinoma cell proliferation and migration by targeting the
miR-374b-5p/SMG1 signaling pathway. J Cell Physiol.
234:18825–18836. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hu B, Shi G, Li Q, Li W and Zhou H: Long
noncoding RNA XIST participates in bladder cancer by downregulating
p53 via binding to TET1. J Cell Biochem. 120:6330–6338. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shan G, Tang T, Xia Y and Qian HJ: MEG3
interacted with miR-494 to repress bladder cancer progression
through targeting PTEN. J Cell Physiol. 235:1120–1128. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang F, Zu Y, Zhu S, Yang Y, Huang W, Xie
H and Li G: Long noncoding RNA MAGI2-AS3 regulates CCDC19
expression by sponging miR-15b-5p and suppresses bladder cancer
progression. Biochem Biophys Res Commun. 507:231–235. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kouhsar M, Azimzadeh Jamalkandi S, Moeini
A and Masoudi-Nejad A: Detection of novel biomarkers for early
detection of non-muscle-invasive bladder cancer using competing
endogenous RNA network analysis. Sci Rep. 9:84342019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang H, Zhu C, Zhao Y, Li M, Wu L, Yang
X, Wan X, Wang A, Zhang MQ, Sang X and Zhao H: Long non-coding RNA
expression profiles of hepatitis C virus-related dysplasia and
hepatocellular carcinoma. Oncotarget. 6:43770–43778. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li PD, Chen P, Peng X, Ma C, Zhang WJ and
Dai XF: HOXC6 predicts invasion and poor survival in hepatocellular
carcinoma by driving epithelial-mesenchymal transition. Aging
(Albany NY). 10:115–130. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hu Q, Qin Y, Ji S, Xu W, Liu W, Sun Q,
Zhang Z, Liu M, Ni Q, Yu X and Xu X: UHRF1 promotes aerobic
glycolysis and proliferation via suppression of SIRT4 in pancreatic
cancer. Cancer Lett. 452:226–236. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zou J, Li H, Huang Q, Liu X, Qi X, Wang Y,
Lu L and Liu Z: Dopamine-induced SULT1A3/4 promotes EMT and cancer
stemness in hepatocellular carcinoma. Tumour Biol.
39:10104283177192722017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Jiang LP, Fan SQ, Xiong QX, Zhou YC, Yang
ZZ, Li GF, Huang YC, Wu MG, Shen QS, Liu K, et al: GRK5 functions
as an oncogenic factor in non-small-cell lung cancer. Cell Death
Dis. 9:2952018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chen L, Hu W, Li G, Guo Y, Wan Z and Yu J:
Inhibition of miR-9-5p suppresses prostate cancer progress by
targeting starD13. Cell Mol Biol Lett. 24:202019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhou Y, Wang W, Wei R, Jiang G, Li F, Chen
X, Wang X, Long S, Ma D and Xi L: Serum bradykinin levels as a
diagnostic marker in cervical cancer with a potential mechanism to
promote VEGF expression via BDKRB2. Int J Oncol. 55:131–141.
2019.PubMed/NCBI
|
|
64
|
Chen XD, Zhu MX and Wang SJ: Expression of
long non-coding RNA MAGI2-AS3 in human gliomas and its prognostic
significance. Eur Rev Med Pharmacol Sci. 23:3455–3460.
2019.PubMed/NCBI
|
|
65
|
Ni W, Zhang Y, Zhan Z, Ye F, Liang Y,
Huang J, Chen K, Chen L and Ding Y: A novel lncRNA uc.134 represses
hepatocellular carcinoma progression by inhibiting CUL4A-mediated
ubiquitination of LATS1. J Hematol Oncol. 10:912017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhang L, Li S, Choi YL, Lee J, Gong Z, Liu
X, Pei Y, Jiang A, Ye M, Mao M, et al: Systematic identification of
cancer-related long noncoding RNAs and aberrant alternative
splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
Lung Cancer. 109:21–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Jiang MM, Mai ZT, Wan SZ, Chi YM, Zhang X,
Sun BH and Di QG: Microarray profiles reveal that circular RNA
hsa_circ_0007385 functions as an oncogene in non-small cell lung
cancer tumorigenesis. J Cancer Res Clin Oncol. 144:667–674. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Chen Y, Yang Z, Deng B, Wu D, Quan Y and
Min Z: Interleukin 1β/1RA axis in colorectal cancer regulates tumor
invasion, proliferation and apoptosis via autophagy. Oncol Rep.
43:908–918. 2020.PubMed/NCBI
|
|
69
|
Zhao HQ, Dong BL, Zhang M, Dong XH, He Y,
Chen SY, Wu B and Yang XJ: Increased KIF21B expression is a
potential prognostic biomarker in hepatocellular carcinoma. World J
Gastrointest Oncol. 12:276–288. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wolf D, Fiegl H, Zeimet AG, Wieser V,
Marth C, Sprung S, Sopper S, Hartmann G, Reimer D and Boesch M:
High RIG-I expression in ovarian cancer associates with an
immune-escape signature and poor clinical outcome. Int J Cancer.
146:2007–2018. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Shiseki M, Ishii M, Miyazaki M, Osanai S,
Wang YH, Yoshinaga K, Mori N and Tanaka J: Reduced PLCG1 expression
is associated with inferior survival for myelodysplastic syndromes.
Cancer Med. 9:460–468. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sun Q, Hao Q and Prasanth KV: Nuclear long
noncoding RNAs: Key regulators of gene expression. Trends Genet.
34:142–157. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Liu F, Cai Y, Rong X, Chen J, Zheng D,
Chen L, Zhang J, Luo R, Zhao P and Ruan J: MiR-661 promotes tumor
invasion and metastasis by directly inhibiting RB1 in non small
cell lung cancer. Mol Cancer. 16:1222017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Liang X, Li Z, Men Q, Li Y, Li H and Chong
T: MiR-326 functions as a tumor suppressor in human prostatic
carcinoma by targeting mucin1. Biomed Pharmacother. 108:574–583.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Li Y, Zheng F, Xiao X, Xie F, Tao D, Huang
C, Liu D, Wang M, Wang L, Zeng F and Jiang G: CircHIPK3 sponges
miR-558 to suppress heparanase expression in bladder cancer cells.
EMBO Rep. 18:1646–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Li D, Hao X and Song Y: An integrated
analysis of key microRNAs, regulatory pathways and clinical
relevance in bladder cancer. Onco Targets Ther. 11:3075–3085. 2018.
View Article : Google Scholar : PubMed/NCBI
|
